Article
Early Detection of the Pathogenetic Variants of HRR Genes in Prostate Cancer: Critical Analysis and Experimental Design
2024-12-02
Abstract excerpt
It has been shown that the pathogenic variants (PVs) of the DDR genes, whether of a germinal or somatic nature, represent a predictive biomarker of high sensitivity to treatment with inhibitors of the enzyme PARP, in patients with hormone-resistant metastatic prostate cancer (HRPCa). Moreover, the detection of PVs of the HRR genes in PCa patients can help to define the patient’s prognosis and the choice of the the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 844fc999-20b2-5226-8c6b-c2ee14c42621
- DOI
- 10.20944/preprints202412.0042.v1
